Strong annual sales growth: +9.7% at constant exchange rates

02/05/2014

 

Avignon, 4 February 2014 - Naturex, global leader in specialty plant-based natural ingredients, announces its annual consolidated revenue for fiscal 2013:

€000s

IFRS

FY 2013  FY 2012  Change (%)  Change (%)
 at constant exchange rates  
1st quarter 83,196 73,473 +13.2% +14.4%
2nd quarter 82,558 73,684 +12.0% +12.5%
3rd quarter 76,817 75,973 +1.1% +6.0%
4th quarter 78,215 76,693 +2.0% +6.0%
Annual revenue  320,786  299,823  +7.0%  +9.7% 

The difficult global economic conditions prevailing in 2013 led to slower economic growth, particularly in Western Europe.

In that context, and despite a particularly high comparison base from the prior year's second half, Naturex achieved good annual gains in an ingredients market still sustained by positive underlying trends favour of the natural, health and well-being.

On that momentum, full-year sales reached €320.8 million, up 7% from 2012. At constant exchange rates, sales rose 9.7% including organic growth of 8.0% and 1.7% from changes in Group structure (business of Decas Botanical Synergies consolidated as of 19 September 2012). Foreign exchange trends (-2.7% for the year) impacted mainly 2013 third and fourth quarter sales due to the significant depreciation of several currencies versus the euro, including the US and Australian dollars and selected emerging country currencies (Brazil, Mexico, China, Russia, India, etc.).

 

Nutrition & Health driving growth 

€000s

IFRS

FY 2013  FY 2012 

Change 

(%) 

Revenue mix 

(%) 

Change (%)
 at constant exchange rates 
Food & Beverage 184,085 188,828 -2.5% 57.4% +0.4%
Nutrition & Health 112,896 92,295 +22.3% 35.2% +24.8%
Personal Care 5,798 4,797 +20.9% 1.8% +24.0%
Toll-Manufacturing and misc. 18,007 13,903 +29.5% 5.6% +29.9%

 

 

Growth in all geographic regions 

€000s

IFRS

FY 2013  FY 2012* 

Change 

(%) 

Revenue mix 

(%) 

Change (%)
 at constant exchange rates 
 
Europe/Africa 150,635 142,291 +5.9% 47.0% +6.9%
Americas 130,254 120,892 +7.7% 40.6% +11.4%
Asia/Pacific 39,897 36,640 +8.9% 12.4% +14.7%
               

* To take into account the geographic breakdown of our Sales Divisions, countries of the Middle East region previously included in Europe/Africa are henceforth presented within the Asia/Pacific region. The breakdown by geographic region for 2012 annual sales in consequence takes into account this new presentation. 

 

Growth performances for the three geographical regions were less uneven, despite currency effects, due to positive contributions from emerging countries that account for 17.7% of Group sales.

"Naturex achieved a very good performance for 2013 in a particularly challenging economic environment in terms of growth and despite an unfavourable comparison base", commented Thierry Lambert, Naturex's Chairman-CEO. "This positive momentum reflects the work of our teams who contribute throughout the world to Naturex's development by providing an international customer base with a service and innovation driven offering. In 2014, we must continue to progress in a still difficult macroeconomic environment, focusing on our organic growth while pursuing our strategy of selective acquisitions."

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com 

 Financial schedule 

-          Results – FY 2013 31 March 2014

Upcoming events 

-          Analysts meeting (SFAF - French Society of Financial Analysts), Paris 2 April 2014

 

Naturex has been listed on NYSE Euronext Paris, Compartment B (MidCaps), since October 1996.

 

Total number of shares comprising the share capital: 7,843,251

ISIN FR0000054694

 

Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex’s ADRs are traded over-the-counter in the United States under the symbol NTUXY.

 

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex  

NATUREX is the global leader in specialty plant-based natural ingredients.The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

 

NATUREX’s head office is based in Avignon. The company employs more than 1,450 people and benefits from 8 sourcing offices around the world and high-performance manufacturing operations across 15 sites in Europe, in Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.           

Contacts   

 

Thierry Lambert

Chairman and Chief Executive Officer

Tel: +33 (0)4 90 23 96 89

t.lambert@naturex.com

 

 

 

 

Thierry Bertrand Lambert

Chief Financial Officer

Tel: +33 (0)4 90 23 96 89

t.b.lambert@naturex.com

 

Carole Alexandre

Investor Relations

Tel: +33 (0)4 90 23 78 28

c.alexandre@naturex.com

Anne Catherine Bonjour

Actus Finance Press Relations

Tel: +33 (0)1 53 67 36 93

acbonjour@actus.fr

 

 

 

actu_181_Fichierpdf.pdf
 
of 221
BACK